SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending amidst earnings anticipation and mixed sentiment regarding its path to profitability. While vehicle margins have expanded, concerns remain around overall losses and future guidance, sparking debate among bulls and bears. The community is closely watching for details on Q4 deliveries and potential for profitability.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Google is trending as discussions heat up about its AI capabilities with Gemini 3, potentially challenging competitors like OpenAI and even leading to market share gains against Nvidia in AI chips. Community members are weighing in on Google's long-term potential, with some suggesting it could become the most valuable company, while others caution against overvaluation. The stock's recent surge has sparked debates about an AI bubble and whether Google's valuation is justified.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to a mix of earnings results and AI developments; while revenue slightly beat expectations, EPS disappointed, sparking mixed reactions. Discussions also center on the rapid adoption of Alibaba's Qwen AI app, with investors weighing its potential impact amid wider concerns about AI investments and competition. Mainland investors are showing increased interest in BABA ahead of Q2 results.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending amid positive analyst ratings and optimism around its role in AI infrastructure, particularly following reports of Google's Gemini 3 model utilizing Broadcom's TPUs. Community members are discussing Broadcom's potential to challenge Nvidia's dominance in the AI chip market and anticipating further gains, with some noting recent insider buying as a bullish signal.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA ($NVDA) is trending downwards amid concerns about increased competition from Google's AI chips, with Meta potentially exploring their use; this is raising questions about NVIDIA's long-term dominance despite reassurances of strong fundamentals. The community is debating whether this signals the start of margin erosion and a shift in the AI landscape, while some dismiss the news as overblown, citing NVIDIA's established ecosystem and upcoming catalysts.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

Mawson Infrastructure Group is trending due to increased attention on low-float stocks and its potential in the AI data center and Bitcoin mining sectors. Community discussions highlight the company's low market capitalization relative to its power capacity and revenue, suggesting it may be undervalued. Some investors believe MIGI's compliance pressures and shift towards AI could lead to a short squeeze.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending due to a significant surge, driven by defense deals and strategic investments, particularly in Performance Drone Works. The community is actively discussing the stock's potential breakout, key resistance levels, and possible short squeeze scenarios, while also weighing in on the company's prospects in the drone and critical infrastructure security sectors. Some traders are highlighting Ondas' growing influence in AI-enabled autonomous systems and its expanding footprint in both defense and commercial applications.

Jiayin Group, Inc. engages in the operation of an online individual finance marketplace in China, which connects individual investors and individual borrowers. The company was founded by Dinggui Yan in 2011 and is headquartered in Shanghai, China.

Jiayin Group Inc - ADR

Jiayin Group Inc.

Jiayin Group (JFIN) is trending amid discussions around its earnings and financial health, with community members pointing to a recent earnings report and comparing its valuation to peers. Some investors express concerns about regulatory risks associated with Chinese stocks while others highlight the company's dividend and potential for growth, viewing it as undervalued. The community is also closely monitoring price action and technical indicators for potential entry points.

shark raptor rocket launcher

SRRL is trending as traders discuss its chart patterns and potential for momentum. Community members are noting the "calm" and "organized" movement, suggesting accumulation. Some users are also exchanging information on where to purchase the token, indicating growing interest.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community rallies around the revival of OG meme culture and the potential for significant growth. Active community members emphasize the project's strong, unified base and ongoing building efforts across multiple social platforms. Talk centers on the coin's potential within the meme and crypto landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ETF Areas to Buy on Fed Cuts and Trade Truce Optimism

Fed turns dovish and trade tensions ease. Amid this scenario, tech & growth ETFs could soar along with some other areas. Watch SMH, QQQ, SPYG & IWO as markets may be up for a renewed rally.

<ul class="summary-bullets"><li>ADX-629 was administered orally for one month in four patients with mild to moderate alcohol-associated hepatitis in the study.</li><li>Statistically significant improvement relative to baseline was observed in clinically relevant objective markers of hepatic function and inflammation, the company said.&nbsp;</li><li>The company has, however, &nbsp;now discontinued clinical development of ADX-629 pending further investigator-sponsored clinical testing in Sjögren-Larsson Syndrome.&nbsp; &nbsp;</li></ul>Aldeyra Therapeutics, Inc. (ALDX) on Tuesday announced that its experimental drug candidate ADX-629 demonstrated statistically significant improvement in liver function in patients with alcohol-associated hepatitis in a mid-stage trial.ADX-629 was administered orally for one month in four patients with mild to moderate alcohol-associated hepatitis in the study. Statistically significant improvement relative to baseline was observed in clinically relevant objective markers of hepatic function and inflammation, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.aldeyra.com/news-releases/news-release-details/aldeyra-therapeutics-announces-positive-results-phase-2-clinical">said.</a>No serious adverse events were reported in the trial, the company noted. Furthermore, no adverse events were deemed related to its experimental drug, it added.<h2 class="st-heading-2">Plans Ahead</h2>The company has, however, &nbsp;now discontinued clinical development of ADX-629 pending further investigator-sponsored clinical testing in Sjögren-Larsson Syndrome, a rare genetic disorder.CEO Todd C. Brady said that the company will share details of the recent trial in the future and will now focus its pipeline on ADX-248 and ADX-246 for the treatment of immune-mediated diseases.While ADX-248 is being studied in the treatment of metabolic inflammation, including obesity and hypertriglyceridemia, ADX-246 is being studied for the treatment of dry form of age-related macular degeneration.Aldeyra is committed to developing a robust pipeline of novel therapeutics in a fiscally prudent manner to maintain growth, the CEO noted.The company now expects cash, cash equivalents, and marketable securities to provide operational runway into the second half of 2027.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ALDX">ALDX stock</a> jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels.ALDX stock is down by 0.5% this year and by about 12% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-registrations-slumped-nearly-19-percent-in-eu-in-september-despite-rising-ev-demand/cLGjW7LR3HL">Tesla Registrations Slumped Nearly 19% In EU In September Despite Rising EV Demand</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the Aldeyra Therapeutics logo is seen displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Aldeyra Reports Positive Mid-Stage Data For Liver Drug, Discontinues Further Development

Statistically significant improvement relative to baseline was observed in clinically relevant objective markers of hepatic function and inflammation in the study, the company said. 

Equity

<ul class="summary-bullets"><li>The company announced the exercise of existing warrants held by an institutional investor.</li><li>The investor will receive new registered warrants to purchase up to 22.4 million shares of its common stock at an exercise price of $2.00 for the exercise of existing warrants.&nbsp;</li><li>The transaction is expected to close on or about October 28, the company said.&nbsp; &nbsp;</li></ul>Shares of SELLAS Life Sciences Group, Inc. (SLS) slumped 6% on Monday after the company announced the exercise of existing warrants held by an institutional investor for $31 million in gross proceeds.The warrants were previously issued in March and August 2024, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.sellaslifesciences.com/news/News-Details/2025/SELLAS-Life-Sciences-Group-Announces-Exercise-of-Existing-Warrants-Held-by-a-Current-Institutional-Investor-for-31-Million-in-Gross-Proceeds/default.aspx">said</a>. The investor will receive new registered warrants to purchase up to 22.4 million shares of its common stock at an exercise price of $2.00 for the exercise of existing warrants.The new warrants will be exercisable immediately and will expire five years from the date of issuance, the company said.The closing of the translation is expected to occur on or about October 28, it added.Sellas is a late-stage clinical biopharmaceutical company focused on developing novel cancer therapeutics. Its lead product candidate, called GPS, is licensed from Memorial Sloan Kettering Cancer Center and targets a protein present in an array of tumor types.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around<a href="https://stocktwits.com/symbol/SLS"> SLS stock</a> fell from ‘extremely bullish’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.A Stocktwits user recommended holding the stock, opining that it will now go higher.<stembedurl>https://stocktwits.com/Kevoo/message/633843705</stembedurl>Another dismissed concerns of dilution, terming the warrant exercise a “not that big deal.”<stembedurl>https://stocktwits.com/Risulom/message/633841655</stembedurl> In September, the company <a href="https://stocktwits.com/news-articles/markets/equity/sellas-life-sciences-stock-in-spotlight-after-institutional-investor-exercises-existing-warrants/chwNYhvRdvv">announced</a> that an institutional investor had exercised the warrants it held to purchase up to 19.69 million shares of the company’s common stock for gross cash proceeds of approximately $23.6 million. The warrants were previously issued in January 2025, the company then said.SLS stock is up by 80% this year and by about 54% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/dyne-therapeutics-stock-soars-after-rival-avidity-biosciences-gets-acquired-by-novartis/cLG0X2XR3u7">Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Esperion’s stock (ESPR) has risen 40.5% so far in 2025. (Representative Image: Getty Images)

Why Is SELLAS Life Sciences Stock Falling Today?

Shares of SELLAS Life Sciences Group, Inc. (SLS) slumped 5% on Monday after the company announced the exercise of existing warrants held by an institutional investor for $31 million in gross proceeds.

Why Is SELLAS Life Sciences (SLS) Stock Falling Today?

Tvardi Therapeutics (TVRD) on Monday said that its TTI-101, being evaluated in idiopathic pulmonary fibrosis (IPF), showed no benefit over placebo in a mid-stage trial.The trial was designed to assess safety, pharmacokinetics, and exploratory outcomes related to lung function in patients with IPF. Idiopathic Pulmonary Fibrosis is a progressive lung disease where lung tissue thickens and scars, making it difficult to breathe. However, the study did not meet its goals, and no statistically significant differences between placebo and treatment arms were observed after a preliminary review of exploratory efficacy, it said.Shares of the company plummeted 87% in Monday’s pre-market session. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/TVRD">TVRD stock</a> rose from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.Tvardi said that preliminary data showed that patients’ baseline characteristics were mostly similar across treatment arms, including those who received the two doses of TTI-101 or those who received a placebo in the trial. Furthermore, lower discontinuation rates were observed in the placebo group compared to the therapy-treated arms, it added.The company also noted that patients who demonstrated changes in the lung’s Forced Vital Capacity (FVC) were 41% for the placebo, and 39% and 44% for the 400mg and 800mg TTI-101-treated arms, respectively.“In the aggregate, we did not observe a benefit of TTI-101 treatment in this IPF study. The limited data set, high variability within treatment arms, and unexpected performance of the placebo arm make it difficult to provide more definitive conclusions at this time,” CEO Imran Alibhai said.The CEO added that the company is now conducting additional analyses to understand the trial findings further. He also noted that the company is on track to report preliminary data from the mid-stage trial of TTI-101 in hepatocellular carcinoma.TVRD stock has risen about 127% this year and more than quadrupled over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-reportedly-commences-production-ramp-up-at-shanghai-gigafactory/ch6SiqpR3kW">Tesla Reportedly Commences Production Ramp-Up At Its Shanghai Gigafactory</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today?

The company said that its investigational drug did not meet its goal in a study, and no statistically significant differences between placebo and treatment arms were observed after preliminary review of exploratory efficacy. 

Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar?

SoundHound AI, Inc.(SOUN) on Wednesday said it has teamed up with Apivia Courtage, part of the AEMA Group, to bring advanced AI agents into the insurer’s contact centers using SoundHound’s Amelia 7 platform.Under this collaboration, Apivia Courtage will roll out Amelia 7, an AI agent system designed to act autonomously, as a key component of its digital overhaul strategy, building on the success with SoundHound’s platform, which resulted in a 20% productivity boost.<a href="https://stocktwits.com/symbol/SOUN">SoundHound AI stock</a> traded over 8% higher on Wednesday afternoon. On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘neutral’ territory the previous day amid ‘normal message volume levels.<figure class="image"><img style="aspect-ratio:925/100;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_08_130638_png_e64e4f8927.webp" alt="SOUN’s Sentiment Meter and Message Volume as of 12:45 p.m. ET on Oct. 8, 2025 | Source: Stocktwits" width="925" height="100"><figcaption>SOUN’s Sentiment Meter and Message Volume as of 12:45 p.m. ET on Oct. 8, 2025 | Source: Stocktwits</figcaption></figure>The stock saw a 161% increase in user message count in the last month, as per platform data. A Stocktwits user expressed confidence in the partnership, stating that the company is a “huge player” in France.<stembedurl>https://stocktwits.com/Ibiolegends/message/631509252</stembedurl>Amelia’s architecture blends large language models’ reasoning and planning with structured rule‑driven workflows. It also supports escalation to humans when needed. The AI agents operate across multiple channels, including voice, chat, and text.With Amelia 7’s “agentic” capabilities, Apivia aims to let customers self‑serve on more types of inquiries without human intervention. The AI agents will interpret multiple intents in a single interaction, carry out tasks like identity verification via one-time passwords, answer policy questions, update contact details, compute the financial impact of contract changes, and initiate quotes or book meetings with advisors.Since 2023, the two companies have worked together to integrate AI agents alongside human staff at Apivia’s call centers. SoundHound AI stock has gained over 317% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/amd-hits-all-time-high-after-nvidia-ceo-jensen-huang-calls-offering-10-percent-stake-to-open-ai-clever/ch6EpkDR30b">AMD Hits All-Time High After Nvidia CEO Jensen Huang Calls Offering 10% Stake To OpenAI ‘Clever’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, Amelia logo is being displayed on a mobile phone screen in front of a monitor displaying SoundHoundAI logo in Ankara, Turkiye on August 27, 2024. 

SoundHound, Apivia Deploy Agentic AI For Insurance Contact Centers: Retail Sentiment Jumps

Under the partnership, Apivia Courtage will roll out Amelia 7, an AI agent system designed to act autonomously, building on earlier success where SoundHound’s platform boosted productivity by 20%.

Small-Cap Wins in Q3: Top-Performing ETFs in Focus 

Small caps staged a comeback in Q3, with ETFs like FESM, RZV, FYX, VTWV, JSML, IWO topping gains. While there are certain tariff risks, the Fed's rate cut potential is a plus. 

SoundHound AI Inc. (SOUN) stock was in the spotlight on Monday morning after the shares received an upgrade from Ladenburg Thalmann, which raised its rating to ‘Buy’ from ‘Neutral’ and raised the price target to $16 from $9.&nbsp;The brokerage cited strong second-quarter (Q2) results and successful execution on large enterprise deals as key reasons for its upgrade, as per TheFly.&nbsp;<a href="https://stocktwits.com/symbol/SOUN">SoundHound AI stock</a> shot up over 13% on Monday morning. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.<figure class="image"><img style="aspect-ratio:955/110;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_11_095242_png_df04a03eb4.webp" alt="SOUN’s Sentiment Meter and Message Volume as of 09:45 a.m. ET on Aug. 11, 2025 | Source: Stocktwits" width="955" height="110"><figcaption>SOUN’s Sentiment Meter and Message Volume as of 09:45 a.m. ET on Aug. 11, 2025 | Source: Stocktwits</figcaption></figure>The stock experienced a 176% increase in user message count over 24 hours, as of Monday morning. A Stocktwits user said the business has ‘great demand’.<stembedurl>https://stocktwits.com/Tekoa/message/624580522</stembedurl>Another user commended the Q2 earnings print.<stembedurl>https://stocktwits.com/paaps/message/624567480</stembedurl>Ladenburg sees sales growth momentum as justifying its increased spending levels. The brokerage remains optimistic about the opportunity in voice-based artificial intelligence, identifying it as one of the most promising early-use cases in the AI space.&nbsp;The firm believes SoundHound’s products cater to businesses that want to integrate AI-driven voice features into their operations.The company’s Q2 revenue jumped 217% year-on-year (YoY) to $42.7 million, beating the analysts’ consensus estimate of $32.88 million, as per Fiscal AI data. The adjusted loss per share of $0.03 came in wider than the consensus estimate of a loss of $0.01.The company raised its FY2025 revenue guidance to a range of $160 million and $178 million. On August 7, SoundHound launched Vision AI, a visual recognition engine built directly into its voice-centric platform.SoundHound AI stock has lost over 24% year-to-date and has gained over 190% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/black-monday-for-monday-dot-com-stock/chruzItRdeT">Black Monday For Monday.Com Stock? Here’s What Co-CEO Roy Mann Said About Google Algorithm Impact</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Binary code displayed on a laptop screen displayed on a laptop screen and SoundHound AI logo displayed on a phone screen are seen in this illustration photo taken in Krakow, Poland on August 8, 2025. 

SoundHound Stock Surged 13% Today – And Ladenburg Thalmann Has A New Price Target 

The firm cited strong second-quarter results and successful execution on large enterprise deals as key reasons for the upgrade.

SoundHound stock was the top-trending equity ticker on Stocktwits late Thursday as retail investors reacted to the conversational artificial intelligence (AI) company announcing a beat-and-raise quarter.Retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SOUN">SoundHound stock</a> turned to ‘extremely bullish’ (88/100) by late Thursday from ‘neutral’ a day ago. The message volume also picked up pace to ‘extremely high’ levels.&nbsp;The 24-hour message volume change leading up to late Thursday was about 500%.<figure class="image"><img style="aspect-ratio:618/54;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_07_at_10_15_05_PM_png_18725d4ece.webp" alt="Screenshot 2025-08-07 at 10.15.05 PM.png" width="618" height="54"><figcaption>SOUN sentiment and message volume as of 10:15 p.m. ET, Aug. 7 | source: Stocktwits</figcaption></figure>Santa Clara, California-based SoundHound reported a loss of $0.03 per share on an adjusted basis for the second quarter of the fiscal year 2025, narrower than the year-ago loss of $0.04 and the Factset-compiled consensus of $0.05 per share.Revenue climbed 217% year-over-year to $42.68 million, sharply higher than the $32.9-million consensus estimate.Co-founder and CEO Keyvan Mohajer said, “In SoundHound’s strongest ever quarter, many of our previous strategic moves delivered high-impact results with growth across every business unit.”“We realized significant new wins as well as cross-sell deals, demonstrating the incredible opportunity we predicted with our 2024 acquisitions.”SoundHound ended the quarter with cash and cash equivalents of $230 million as of June 30 and boasted of no debt on its balance sheet.The company raised its full-year revenue outlook to a range of $160 million to $178 million from a range of $157 million to $177 million.Underlining the massive potential for conversational AI,&nbsp;Mark Zuckerberg’s Meta&nbsp;Platforms Inc.&nbsp;made its second voice AI startup acquisition, WaveForms, according to a report by The Information, just a month after purchasing PlayAI.Commenting on Stocktwits, a bullish watcher&nbsp;noted that a majority of the volume in SoundHound stock over the past week was from dark pool or off-exchange transactions. They also noted that the short interest was high,&nbsp;which they considered a positive for the underlying stock.<stembedurl>https://stocktwits.com/notihimself/message/624253898</stembedurl>The short interest in the stock is currently at 30.32%, according to Koyfing, and it has remained above this level since late May.Another user&nbsp;considered the stock price to be too low, noting that it was trading at double the current levels at the start of the year and that the earnings report indicated the company was performing well.<stembedurl>https://stocktwits.com/DakotaDan1/message/624252035</stembedurl>SoundHound stock has grossly underperformed the broader market, having lost 46% this year. In overnight trading, the stock was up over 14%, and if&nbsp;gains carry over into Friday’s session, it&nbsp;would mark its best session since late May, according to Koyfin data.The Koyfin-compiled average analysts’ price target for the stock is $11.81, implying upside potential of over 10%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-stock-marks-worst-day-in-25-years-as-weight-loss-pill-data-disappoints-analysts-divided-but-retail-bets-on-rebound/chrVvOxRd3V">Eli Lilly Stock Marks Worst Day In 25 Years As Weight-Loss Pill Data Disappoints: Analysts Divided But Retail Bets On Rebound</a>

SoundHound Retail Traders Brace For More Stock Gains After Voice AI Player Reports ‘Strongest-Ever Quarter’

The company’s Q2 revenue soared 217% year-over-year to $42.68 million, sharply higher than the $32.9-million consensus estimate.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 Growth ETF

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with Alphabet ($GOOGL) stock as it hits fresh all-time highs?

Current Price	$316.08
Prev Close	$308.52
Open	$309.78
Dividend Yield	N/A
50-Day Moving Average	$322.21
Beta	N/A
Avg. Volume	444,868.70
PE Ratio	N/A

52-Week High	$337.26
52-Week Low	$219.19
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

IWO
iShares Russell 2000 Growth ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IWO News

IWOiShares Russell 2000 Growth ETF